TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30672196

Group type: EXPERIMENTAL
Intervention: Heat sensitive moxibustion combined with articular injection of triamcinolone, 2 courses, 2 weeks as a course, 5 times a week.
Number of subjects: 67

Group type: COMPARATOR
Intervention: Articular injection of triamcinolone, 2 courses, 2 times as a course, once every 5 days.
Number of subjects: 67
Study: 27146064

Group type: EXPERIMENTAL
Intervention: Design effect approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Analytical method
Number of subjects: 0
Study: 23907526

Group type: EXPERIMENTAL
Intervention: Salinity increase (from 5 to 30 psu)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salinity decrease (from 30 to 5 psu)
Number of subjects: 0
Study: 22460270

Group type: EXPERIMENTAL
Intervention: Docetaxel + Sunitinib (DS arm: docetaxel 60 mg m(‐2) every 3 weeks + sunitinib 37.5 mg every day)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Docetaxel only (D only arm: 60 mg m(‐2), every 3 weeks)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Docetaxel + Sunitinib (DS arm)
Number of subjects: 107
Study: 19680302

Group type: EXPERIMENTAL
Intervention: Wearing socks over normal footwear
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual practice (unadulterated footwear)
Number of subjects: 30
Study: 17218893

Group type: EXPERIMENTAL
Intervention: Continuous-exercise
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Intermittent-games
Number of subjects: 19

Group type: COMPARATOR
Intervention: Rest condition
Number of subjects: 19
Study: 16263857

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 60

Group type: COMPARATOR
Intervention: Divalproex
Number of subjects: 60
Study: 12011193

Group type: EXPERIMENTAL
Intervention: Walk in to Work Out pack
Number of subjects: 295

Group type: COMPARATOR
Intervention: Control group (received the pack six months later)
Number of subjects: 295
Study: 10203159

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 56

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 56
Study: 7785637

Group type: EXPERIMENTAL
Intervention: SmartPrep
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control (standard 70-sec delay)
Number of subjects: 109
Study: 1694714

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 150 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Terfenadine 180 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 150 mg + Terfenadine 180 mg
Number of subjects: 17
Study: 7392399

Group type: EXPERIMENTAL
Intervention: Complex stage-by-stage rehabilitation
Number of subjects: 233

Group type: COMPARATOR
Intervention: Control group (no rehabilitation)
Number of subjects: 233
Study: 29160135

Group type: EXPERIMENTAL
Intervention: Dienogest therapy (P group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: No therapy (C group)
Number of subjects: 70
Study: 26259627

Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 0

Group type: COMPARATOR
Intervention: hERG potassium channel blocking drugs (Dofetilide and Moxifloxacin)
Number of subjects: 0
Study: 25194614

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299 v (5 × 10(9) cfu per capsule, 2 capsules daily for 8 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (2 capsules daily for 8 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (L. plantarum 299 v and placebo)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299 v
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22669171

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 20472253

Group type: EXPERIMENTAL
Intervention: Fish oil (1.5 g of n‐3 long‐chain polyunsaturated fatty acid/day)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Vegetable oil (control)
Number of subjects: 78
Study: 18343039

Group type: EXPERIMENTAL
Intervention: 17beta‐estradiol combined with norethisterone acetate
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: High levels of testosterone, LH, and FSH
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 16212456

Group type: EXPERIMENTAL
Intervention: Color duplex ultrasound (CDUS)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Computed tomography (CT)
Number of subjects: 178
Study: 12909222

Group type: COMPARATOR
Intervention: External beam radiotherapy (EBRT) alone (Group 1)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combination of external beam radiotherapy (EBRT) and high-dose-rate intraluminal brachytherapy (ILBT) (Group 2)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combination of EBRT and ILBT (Group 2)
Number of subjects: 31

Group type: COMPARATOR
Intervention: EBRT alone (Group 1)
Number of subjects: 31
Study: 10318656

Group type: EXPERIMENTAL
Intervention: Eptifibatide (high-dose)
Number of subjects: 10948

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10948
Study: 8852097

Group type: EXPERIMENTAL
Intervention: Continuing education programme on pain assessment and management
Number of subjects: 106
Study: 1776336

Group type: EXPERIMENTAL
Intervention: Combination of PGI2 and molsidomine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single administration of PGI2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single administration of molsidomine
Number of subjects: 0
Study: 6408274

Group type: EXPERIMENTAL
Intervention: Heparin (1000 units per liter)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (no heparin)
Number of subjects: 34
Study: 30547696

Group type: EXPERIMENTAL
Intervention: Computerized Cognitive Training (CCT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Nonactive control condition
Number of subjects: 53
Study: 31783862

Group type: EXPERIMENTAL
Intervention: Luteal phase supplementation with triptorelin (either as a single bolus or multiple injections)
Number of subjects: 1344

Group type: COMPARATOR
Intervention: Luteal phase with only progesterone (control group)
Number of subjects: 1344
Study: 29972000

Group type: EXPERIMENTAL
Intervention: Yin-meridian group (acupuncture at Xuehai (SP 10), Yinlingquan (SP 9), Sanyinjiao (SP 6), Taixi (KI 3), Taichong (LR 3) along yin meridians)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Yang-meridian group (acupuncture at Futu (ST 32), Zusanli (ST 36), Yanglingquan (GB 34), Guangming (GB 37), Xuanzhong (GB 39) along yang meridians)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Rehabilitation group (routine rehabilitation treatment)
Number of subjects: 90
Study: 26932144

Group type: EXPERIMENTAL
Intervention: Erythropoietin (33,000 international units intravenously for 3 consecutive days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (0.9% saline administered intravenously)
Number of subjects: 100
Study: 24479668

Group type: EXPERIMENTAL
Intervention: Aspheric IOL (Tecnis, Z9000, AMO)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Spherical IOL (CeeOn Edge, 911A, AMO)
Number of subjects: 30
Study: 22405027

Group type: COMPARATOR
Intervention: Single intervention group (contact at baseline only)
Number of subjects: 4678

Group type: COMPARATOR
Intervention: Dual intervention group (contact at baseline and 3 months)
Number of subjects: 4678

Group type: EXPERIMENTAL
Intervention: Overall intervention (computer-tailored feedback and information sheet)
Number of subjects: 4678
Study: 20846441

Group type: EXPERIMENTAL
Intervention: Weekly 30-minute massage sessions
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Massages plus stretching exercises performed twice a day
Number of subjects: 45

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 45
Study: 17715422

Group type: EXPERIMENTAL
Intervention: Selegiline transdermal system (6 mg/24 h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral selegiline (10 mg)
Number of subjects: 0
Study: 16354864

Group type: EXPERIMENTAL
Intervention: Noninvasive mechanical ventilation (NIMV) through a face mask in pressure-support mode plus positive end-expiratory pressure
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CMV) through a tracheal tube
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Noninvasive mechanical ventilation (NIMV)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CMV)
Number of subjects: 64
Study: 12077684

Group type: EXPERIMENTAL
Intervention: Prostacyclin (PGl 2)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination of PGl 2 and aprotinin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Patients with PPS or SIRS
Number of subjects: 40
Study: 9654756

Group type: EXPERIMENTAL
Intervention: Implicit Association Test (IAT) measuring differential association of concepts with attributes.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implicit Association Test (IAT)
Number of subjects: 0
Study: 8749880

Group type: EXPERIMENTAL
Intervention: Disopyramide (2 mg/kg)
Number of subjects: 12
Study: 2522723

Group type: EXPERIMENTAL
Intervention: Celiprolol (200, 400, 600 mg/day)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 30900658

Group type: EXPERIMENTAL
Intervention: Transdermal diclofenac patch
Number of subjects: 20

Group type: COMPARATOR
Intervention: Oral diclofenac sodium (100 mg twice daily)
Number of subjects: 20
Study: 27993667

Group type: EXPERIMENTAL
Intervention: Convective radiofrequency thermal therapy with the Rezūm® System
Number of subjects: 197

Group type: COMPARATOR
Intervention: Control group (rigid cystoscopy with simulated active treatment)
Number of subjects: 197
Study: 24801275

Group type: EXPERIMENTAL
Intervention: Exercise alone
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Exercise with paced auditory serial addition task
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Exercise with Tetris
Number of subjects: 36
Study: 22807253

Group type: EXPERIMENTAL
Intervention: MTX + prednisone (10 mg of prednisone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MTX + placebo
Number of subjects: 0
Study: 16490095

Group type: EXPERIMENTAL
Intervention: Entonox (50% nitrous oxide and oxygen)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intravenous morphine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 14
Study: 12932067

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with hyperbaric bupivacaine 0.5% 5 mg and fentanyl 25 microg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Total intravenous anaesthesia with propofol and remifentanil
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Total intravenous anaesthesia
Number of subjects: 40
Study: 10720278

Group type: EXPERIMENTAL
Intervention: 0.1 microg/kg rhNGF
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: 0.3 microg/kg rhNGF
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Both doses of NGF
Number of subjects: 270
Study: 8639017

Group type: EXPERIMENTAL
Intervention: Counseling by hospital patient representatives
Number of subjects: 190

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 190
Study: 1641137

Group type: EXPERIMENTAL
Intervention: Pemoline
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 6435046

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Penicillin V
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 30474909

Group type: EXPERIMENTAL
Intervention: Active SMS with hypertension specific management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive SMS (health behaviors SMS alone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active SMS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive SMS
Number of subjects: 0
Study: 29038317

Group type: EXPERIMENTAL
Intervention: £0.10 levy on sugar-sweetened beverages (SSBs)
Number of subjects: 37
Study: 25575599

Group type: EXPERIMENTAL
Intervention: Personalized mail-based contact strategy
Number of subjects: 308

Group type: COMPARATOR
Intervention: Generic mail-based contact strategy
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Personalized telephone-based contact strategy
Number of subjects: 308

Group type: COMPARATOR
Intervention: Generic telephone-based contact strategy
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Age ≤40 years
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Minority race
Number of subjects: 308
Study: 23769413

Group type: EXPERIMENTAL
Intervention: Active TMS
Number of subjects: 142

Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 142
Study: 20831758

Group type: EXPERIMENTAL
Intervention: Bovine bone mineral (BioOss(®)) seeded with mononuclear stem cells harvested from the posterior iliac crest
Number of subjects: 12

Group type: COMPARATOR
Intervention: Bovine bone mineral (BioOss(®)) mixed with autogenous bone (harvested from the retromolar area)
Number of subjects: 12
Study: 19111485

Group type: EXPERIMENTAL
Intervention: Cryostripping
Number of subjects: 120

Group type: COMPARATOR
Intervention: Endovenous laser ablation
Number of subjects: 120
Study: 17904982

Group type: EXPERIMENTAL
Intervention: Initial metabolic score of 0
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Initial metabolic score of 1
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Initial metabolic score of 2 or more
Number of subjects: 556
Study: 15066528

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) at 5 Hz, 100 pulses, 80% threshold for corticobulbar activation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Repetitive transcranial magnetic stimulation (rTMS) at 1 Hz
Number of subjects: 12

Group type: COMPARATOR
Intervention: Repetitive transcranial magnetic stimulation (rTMS) at 10 Hz
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study: 11136913

Group type: EXPERIMENTAL
Intervention: Low bone mineral density (BMD) in female stroke patients
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Lowest quartile of BMD in women
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Reduction in BMD
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Low BMD in women
Number of subjects: 63
Study: 9628239

Group type: EXPERIMENTAL
Intervention: GLP‐1 (7‐36 amide)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl with 1% human serum albumin)
Number of subjects: 10
Study: 7886781

Group type: EXPERIMENTAL
Intervention: IVR 400 micrograms/kg plus DEC 6 mg/kg
Number of subjects: 57

Group type: COMPARATOR
Intervention: IVR 400 micrograms/kg
Number of subjects: 57

Group type: COMPARATOR
Intervention: DEC 6 mg/kg
Number of subjects: 57
Study: 3126636

Group type: EXPERIMENTAL
Intervention: 10 mg nitroglycerin (NTG) patch
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 24
Study: 31628507

Group type: EXPERIMENTAL
Intervention: OSU6162
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 30829679

Group type: EXPERIMENTAL
Intervention: 1.5 g of lactoferrin and 0.2 g of lysozyme daily for 16 weeks
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study: 28697797

Group type: EXPERIMENTAL
Intervention: SELF-FIT intervention (experimental group)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 26
Study: 25332420

Group type: EXPERIMENTAL
Intervention: Carboplatin plus irinotecan
Number of subjects: 370

Group type: COMPARATOR
Intervention: Carboplatin plus etoposide
Number of subjects: 370
Study: 24294684

Group type: EXPERIMENTAL
Intervention: Specially processed cereal (SPC) treatment
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 39
Study: 21683053

Group type: EXPERIMENTAL
Intervention: Audio feedback with cognitive preparation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Audio feedback only
Number of subjects: 40
Study: 18270751

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 16487947

Group type: EXPERIMENTAL
Intervention: Dyslexic adults
Number of subjects: 12

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 12
Study: 15552536

Group type: EXPERIMENTAL
Intervention: Carbamazepine (600 mg/day) added to fluphenazine (5-10 mg/day)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sole fluphenazine (5-10 mg/day)
Number of subjects: 11
Study: 11051235

Group type: EXPERIMENTAL
Intervention: CVD-BIO (Cisplatin, Vinblastine, Dacarbazine followed by IL-2 and IFN-alpha2b)
Number of subjects: 82

Group type: COMPARATOR
Intervention: CVD (Cisplatin, Vinblastine, Dacarbazine)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: CVD-BIO
Number of subjects: 82
Study: 9089819

Group type: EXPERIMENTAL
Intervention: Antipsychotic medications
Number of subjects: 22

Group type: COMPARATOR
Intervention: No antipsychotic medications
Number of subjects: 22
Study: 1447391

Group type: EXPERIMENTAL
Intervention: Metronidazole 25% dental gel administered 1 x a week for 2 weeks
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Metronidazole 15% dental gel applied 1 x a week for 2 weeks
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Metronidazole 15% dental gel applied 2 x a week for 2 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: Subgingival scaling performed 1 x only
Number of subjects: 61
Study: 2863676

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 31345167

Group type: EXPERIMENTAL
Intervention: Quality Improvement Capacity Assessment (QICA)
Number of subjects: 0
Study: 27817095

Group type: COMPARATOR
Intervention: Polygenic score
Number of subjects: 678

Group type: EXPERIMENTAL
Intervention: Elementary school-based universal preventive intervention
Number of subjects: 678
Study: 27104681

Group type: EXPERIMENTAL
Intervention: Score for Neonatal Acute Physiology‐II
Number of subjects: 171
Study: 25741518

Group type: EXPERIMENTAL
Intervention: Hot pack
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Lukewarm-water-soaked gauze
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control
Number of subjects: 126
Study: 22122217

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 77

Group type: COMPARATOR
Intervention: General Stress Management (GSM)
Number of subjects: 77

Group type: COMPARATOR
Intervention: No Treatment (NT)
Number of subjects: 77
Study: 20858878

Group type: EXPERIMENTAL
Intervention: Self-management counseling plus heart failure education
Number of subjects: 902

Group type: COMPARATOR
Intervention: Heart failure education alone
Number of subjects: 902
Study: 17910618

Group type: EXPERIMENTAL
Intervention: Indinavir combined with low-dose ritonavir
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: Saquinavir combined with low-dose ritonavir
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: Lopinavir combined with low-dose ritonavir
Number of subjects: 656

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 656
Study: 15616073

Group type: EXPERIMENTAL
Intervention: Nefopam 20 mg
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Ketamine 10 mg
Number of subjects: 77

Group type: COMPARATOR
Intervention: Isotonic saline (control group)
Number of subjects: 77
Study: 12391054

Group type: EXPERIMENTAL
Intervention: Naloxone (30 mg iv bolus)
Number of subjects: 18
Study: 10489000

Group type: COMPARATOR
Intervention: Control group (age- and sex-matched)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Subjects with low back pain
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study: 8946182

Group type: EXPERIMENTAL
Intervention: Aircast Air‐Stirrup ankle brace
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: DonJoy R.O.M.‐Walker brace
Number of subjects: 66

Group type: COMPARATOR
Intervention: Both braces
Number of subjects: 66
Study: 1789399

Group type: EXPERIMENTAL
Intervention: Budesonide powder 400 micrograms daily
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Budesonide powder 800 micrograms daily
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Budesonide aerosol 400 micrograms daily
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 116
Study: 6786791

Group type: EXPERIMENTAL
Intervention: Wrapped
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Taped
Number of subjects: 6

Group type: COMPARATOR
Intervention: No external support
Number of subjects: 6

Group type: COMPARATOR
Intervention: Normal (control)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ankle inverting (experimental)
Number of subjects: 6
Study: 31751254

Group type: EXPERIMENTAL
Intervention: Personalization mechanisms in mobile applications (Feedback, Goal Setting, User Targeting, Inter-human Interaction)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Gamification-related elements in mobile applications
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Behavior change theories in mobile applications
Number of subjects: 17
Study: 29665854

Group type: EXPERIMENTAL
Intervention: REACT intervention delivered over 12 months by trained facilitators
Number of subjects: 768

Group type: COMPARATOR
Intervention: Minimal control intervention
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: REACT intervention
Number of subjects: 768
Study: 28912191

Group type: EXPERIMENTAL
Intervention: High energy administration (30 kcal/kg/day) starting within 24 hours of hospital admission
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low energy administration during the first 72 hours of hospital admission
Number of subjects: 0
Study: 26624850

Group type: EXPERIMENTAL
Intervention: TDF-FTC
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 22549800

Group type: EXPERIMENTAL
Intervention: Tele-based nurse-delivered five-session psycho-educational intervention (N = 372)
Number of subjects: 740

Group type: COMPARATOR
Intervention: Usual care (N = 368)
Number of subjects: 740